Dr. Levent Mutlu, MD

Dr. Mutlu practices at Holmes Regional Medical Center in Melbourne, Florida, part of Health First.

Dr. Mutlu's NPI, 1548611981, was assigned on June 27, 2016. Dr. Mutlu graduated from Hacettepe University FOM in 2011. Dr. Mutlu holds Florida license ME167742.

Dr. Mutlu's primary practice is Holmes Regional Medical Center, at 1350 S Hickory St, Melbourne, FL 32901 in Brevard County. The practice phone is (321) 434-7000.

Dr. Mutlu's primary practice is Holmes Regional Medical Center in Melbourne, Florida, part of Health First. Dr. Mutlu is also affiliated with Viera Hospital. The medical group on file is Health First Medical Group (Formerly Mima). Dmand AI also links Dr. Mutlu to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mutlu practices, 6 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Mutlu's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Mutlu's licenses on file in 2 states: Florida and Connecticut.

Dmand AI lists hysterectomy among the conditions Dr. Mutlu treats.

CMS data shows 152 Medicare services from Dr. Mutlu across 4 procedure codes in 2024, for 85 Medicare patients. Medicare paid $12,055 for them. Every service was in an office.

CMS counts 85 Medicare patients who saw Dr. Mutlu in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mutlu's median patient age at 67, with 100% women.

In 2024, Dr. Mutlu wrote 128 Medicare Part D claims for 66 patients. 85% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $78 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Mutlu for performance year 2024, reported as part of a group. Dr. Mutlu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mutlu as offering telehealth. CMS counts 11 procedures of removal of the uterus by Dr. Mutlu, more than 85% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 43 papers to Dr. Mutlu, published from 2014 to 2024. 2022 was the busiest year, with 8. The most frequent topics are Cell Line, Tumor, Ovarian Neoplasms and Uterine Cervical Neoplasms. Dr. Mutlu has published most often in Gynecol Oncol. Dr. Mutlu's most frequent co-authors are Alessandro D. Santin, MD, Blair Colette McNamara, MD and Elena S. Ratner, MD.

CMS Open Payments shows 20 general payments to Dr. Mutlu from 4 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 72% of the total. Ethicon Inc. paid the most, $7,199.

Dr. Mutlu graduated from Hacettepe University FOM in 2011.

Dr. Mutlu is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.